Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins

Cancer Biology and Therapy

Volumn 11, Issue 7, 2011, Pages 651-658

  O'Neill, Ann Marie ^a   Smith, Annette N ^a   Spangler, Elizabeth A ^a   Whitley, Elizabeth M ^a,e   Schleis, Stephanie E ^a   Bird, Richard C ^a   Curiel, David T ^b,c,d,f   Thacker, Erin E ^b   Smith, Bruce F ^a  

^a AUBURN UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e IOWA STATE UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Canine; CD40; Gene therapy; Integrins; Lymphoma; Transduction

Indexed keywords

ADENOVIRUS VECTOR; ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; CD40 ANTIGEN; CD40 LIGAND; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR;

ADENOVIRUS INFECTION; ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER RESISTANCE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA CELL; NONHUMAN; PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VIRUS ENTRY;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD40; CELL LINE, TUMOR; DOGS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTEGRINS; LYMPHOMA; OLIGOPEPTIDES; PROTEIN BINDING; TRANSDUCTION, GENETIC;

EID: 79953298161     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.7.14690     Document Type: Article

References (33)

1. Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000; 18:781-92; PMID: 11107448.
2. Hansen K, Khanna C. Spontaneously and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer 2004; 40:858-80; PMID: 15120042; DOI: 10.1016/j.ejca.2003.11.031.
3. Khalighinejad N, Hariri H, Behnamfar O, Yousefi A, Monemi A. Adenoviral gene therapy in gastric cancer: A review. World J Gastroenterol 2008; 14:180-4; PMID: 18186552; DOI: 10.3748/wjg.14.180.
4. Vattemi E, Claudio PP. Adenoviral gene therapy in head and neck cancer. Drug News Perspect 2006; 19:329; PMID: 16971969.
5. McConnell MJ, Imperiali MJ. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther 2004; 15:1022-33; PMID: 15610603; DOI: 10.1089/hum.2004.15.1022.
6. Cichon F, Schmidt HH, Benhidjeb T, Löser P, Siemer S, Haas R, et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999; 1:360-71; PMID: 10738553.
7. Smith JS, Tian J, Muller J, Byrnes AP. Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease. Gene Ther 2004; 11:431-8; PMID: 14973536; DOI:10.1038/sj.gt.3302149.
8. Bergelson JM, Cunningham JA, Drouguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for coxsackie B virus and adenoviruses 2 and 5. Science 1997; 275:1320132-3; PMID: 9036860; DOI: 10.1126/science.275.5304.1320.
9. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alphavbeta3 and alphavbeta5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69:2257-63; PMID: 7533853.
10. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 1996; 70:4502-8; PMID: 8676475.
11. Marini FC, Yu Q, Wichnam T, Kovesdi I, Andreeff M. Adenovirus as a gene therapy vector for hematopoietic cells. Cancer Gene Ther 2000; 7:816-25; PMID: 10880011.
12. Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, et al. Adenoviral-mediated gene transfer in lymphocytes. Proc Nat Acad Sci USA 1998; 95:13159-64; PMID: 9789058.
13. Matto M, Nuutinen UM, Hakkarainen T, Tallone T, Wahlfors J, Pelkonen J. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - a model for adenoviral gene therapy for B cell malignancies. Int J Mol Med 2006; 17:1057-62; PMID: 16685416.
14. Israel BF, Pickles RJ, Segal DM, Gerard RD, Kenney SC. Enhancement of adenovirus vector entry into CD70-positive B cell lines by using a bispecific CD70-adenovirus fiber antibody. J Virol 2001; 75:5215-21; PMID: 11333903; DOI: 10.1128/JVI.75.11.5215-21.2001.
15. Li L, Wickham TJ, Keegan AD. Efficient transduction of murine B lymphocytes and B lymphoma cell lines by modified adenoviral vectors: enhancement via targeting to FcR and heparan-containing proteins. Gene Ther 2001; 8:938-45; PMID: 11426334.
16. Gonzalez R, Vereecque R, Wickham TJ, Vanrumbeke M, Kovesdi I, Bauters F, et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther 1999; 6:314-20; PMID: 10435081.
17. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111- 35; PMID: 9597126; DOI: 10.1146/annurev.immunol.16.1.111.
18. DeInnocentes P, Agarwal P, Bird RC. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer. J Cell Biochem 2009; 106:491-505; PMID: 19130492; DOI: 10.1002/jcb.22034.
19. Kisseberth WC, Nadella MVP, Breen M, Thomas R, Duke SE, Murahari S, et al. A novel canine lymphoma cell line: a translational and comparitive model for lymphoma research. Leuk Res 2007; 31:1709-20; PMID: 17532464; DOI: 10.1016/j.leukres.2007.04.003.
20. Steplewski Z, Jeglum KA, Rosales C, Weintrub N. Canine lymphoma-associated antigens defined by murine monoclonal antibodies. Cancer Immunol Immunother 1987; 24:197-201; PMID: 3594482.
21. Belousova N, Korokhov N, Krendelschchikova V, Simonenko V, Mikheeva G, Triozzi PL, et al. Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol 2003; 77:11367-77; PMID: 14557622; DOI: 10.1128/JVI.77.21.11367-77.2003.
22. Korokhov N, Mikheeva G, Krendelshchikov A, Belousova N, Simonenko V, Drendelshchikova V, et al. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J Virol 2003; 77:12931-40; PMID: 14645549; DOI: 10.1128/JVI.77.24.12931-40.2003.
23. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70:6839-46; PMID: 8794325.
24. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995; 3:207-20; PMID: 7552690.
25. Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Ectodomain of Coxsackie and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor positive cells. J Virol 2000; 74:6875-84; PMID: 10888627.
26. Bird RC, DeInnocentes P, Lenz S, Thacker EE, Curiel DT, Smith BF. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer. Vet Immunol Immunopath 2008; 123:289-304; PMID: 18423623; DOI: 10.1016/j.vetimm.2008.02. 013.
27. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alphavbeta3 and alphavbeta5 promote adenovirus internalization but not virus attachment. Cell 1993; 73:309-19; PMID: 8477447; DOI: 10.1016/0092-8674(93)90231-E.
28. Majhen D, Ambriovic-Ristov A. Adenoviral vectors - how to use them in cancer gene therapy? Virus Res 2006; 119:121-33; PMID: 16533542; DOI: 10.1016/j.virusres.2006.02.001.
29. Cantwell MJ, Sharma S, Friedmann T, Kipps TJ. Adenovirus vector infection of chronic lymphocytic leukaemia B cells. Blood 1996; 88:4676-83; PMID: 8977261.
30. Ebert O, Wilbert D, Buttgereit P, Ziske C, Flieger D, Schmidt-Wolf IGH. Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC. Genet Vaccines Ther 2004; 2:15; PMID: 15485577; DOI: 10.1186/1479-0556-2-15.
31. Mason NJ, Coughlin CM, Overley B, Cohen JN, Mitchell EL, Colligon TT, et al. RNA-loaded CD40-activated B cells stimulate antigen-specific T cell responses in dogs with spontaneous lymphoma. Gene Ther 2008; 15:955-65; PMID: 18337841; DOI:10.1038/gt.2008.22.
32. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173:705-10; PMID: 1705282.
33. Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J 1997; 16:2294-306; PMID: 9171344; DOI: 10.1093/emboj/16.9.2294.